1. Home
  2. FCUV vs DRMA Comparison

FCUV vs DRMA Comparison

Compare FCUV & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Focus Universal Inc.

FCUV

Focus Universal Inc.

HOLD

Current Price

$1.46

Market Cap

4.2M

Sector

Industrials

ML Signal

HOLD

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

HOLD

Current Price

$1.23

Market Cap

4.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCUV
DRMA
Founded
2012
2014
Country
United States
United States
Employees
N/A
9
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.9M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
FCUV
DRMA
Price
$1.46
$1.23
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
1.7M
71.5K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$255,023.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$650.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.59
52 Week High
$12.83
$7.33

Technical Indicators

Market Signals
Indicator
FCUV
DRMA
Relative Strength Index (RSI) 35.72 41.81
Support Level $0.63 $1.13
Resistance Level $2.44 $1.40
Average True Range (ATR) 0.44 0.09
MACD -0.11 -0.00
Stochastic Oscillator 3.29 0.43

Price Performance

Historical Comparison
FCUV
DRMA

About FCUV Focus Universal Inc.

Focus Universal Inc focuses on commercializing universal smart technology and financial reporting software. It plans to utilize its universal smart technology for smart meters and automation systems, which will be incorporated into IoT devices. The company has developed the five proprietary platform technologies: device on a chip; universal smart instrumentation platform (USIP); 5G ultra-narrowband technology; ultra-narrowband power line communication (PLC) technology; and its financial reporting software. The company consists of two segments: LED and IoT Installation Services, and SEC Financial Software segment. It derives the majority of the revenue from LED and IoT Installation Services segment which handles LED and IoT installation and management business.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

Share on Social Networks: